Baltimore reaches second opioid settlement with CVS on the eve of trial

Baltimore has reached a $45 million settlement with the pharmaceutical distributor CVS as part of a lawsuit the city is pursuing over its opioid epidemic, Mayor Brandon Scott announced late Friday afternoon. The settlement adds to $45 million the city had already secured from a separate drug supplier earlier this year. The decision comes as Baltimore is barely a month out from a scheduled trial date with opioid companies and manufacturers after six years of litigation.